Autoantibodies in CNS trauma and neuropsychiatric disorders: A new generation of biomarkers

Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects

Volumn , Issue , 2015, Pages 399-418

  Kobeissy, Firas Hosni ^a,b,c   Moshourab, Rabih A ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85053496441     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b18126     Document Type: Chapter

References (234)

1. Abdul-Majid, K.B., A. Stefferl, C. Bourquin, H. Lassmann, C. Linington, T. Olsson et al. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scandinavian Journal of Immunology. 55:70-81.
2. Abou-Donia, M.B., M.M. Abou-Donia, E.M. ElMasry, J.A. Monro, and M.F. Mulder. 2013. Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: Biomarkers for nervous system injury. Journal of Toxicology and Environmental Health. Part A. 76:363-380.
3. Aihara, N., H. Tanno, J.J. Hall, L.H. Pitts, and L.J. Noble. 1994. Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood-brain barrier. The Journal of Comparative Neurology. 342:481-496.
4. Amaral, D.G., C.M. Schumann, and C.W. Nordahl. 2008. Neuroanatomy of autism. Trends in Neurosciences. 31:137-145.
5. Ankeny, D.P., Z. Guan, and P.G. Popovich. 2009. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. The Journal of Clinical Investigation. 119:2990-2999.
6. Ankeny, D.P., K.M. Lucin, V.M. Sanders, V.M. McGaughy, and P.G. Popovich. 2006. Spinal cord injury triggers systemic autoimmunity: Evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. Journal of Neurochemistry. 99:1073-1087.
7. Ankeny, D.P., and P.G. Popovich. 2009. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience. 158:1112-1121.
8. Ankeny, D.P., and P.G. Popovich. 2010. B cells and autoantibodies: Complex roles in CNS injury. Trends in Immunology. 31:332-338.
9. Arbour, R.B. 2013. Traumatic brain injury pathophysiology, monitoring, and mechanism-based care. Crit Care Nurs Clin. 25:297-319.
10. Ashwood, P., and J. Van de Water, 2004a. Is autism an autoimmune disease? Autoimmunity Reviews. 3:557-562.
11. Ashwood, P., and J. Van de Water, 2004b. A review of autism and the immune response. Clinical and Developmental Immunology. 11:165-174.
12. Ashwood, P., S. Wills, and J. Van de Water. 2006. The immune response in autism: A new frontier for autism research. Journal of Leukocyte Biology. 80:1-15.
13. Bahmanyar, S., M.C. Moreau-Dubois, P. Brown, F. Cathala, and D.C. Gajdusek. 1983. Serum antibodies to neurofilament antigens in patients with neurological and other diseases and in healthy controls. Journal of Neuroimmunology. 5:191-196.
14. Baig, S., T. Olsson, J. Yu-Ping, B. Hojeberg, M. Cruz, and H. Link. 1991. Multiple sclerosis: Cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scandinavian Journal of Immunology. 33:73-79.
15. Bake, S., J.A. Friedman, and F. Sohrabji. 2009. Reproductive age-related changes in the blood brain barrier: Expression of IgG and tight junction proteins. Microvascular Research. 78:413-424.
16. Baloyannis, S.J., and N.K. Gonatas. 1979. Distribution of anti-HRP antibodies in the central nervous system of immunized rats after disruption of the blood brain barrier. J Neuropathology and Experimental Neurology. 38:519-531.
17. Banks, W.A. 2005. Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Current Pharmaceutical Design. 11:973-984.
18. Bansal, D., F. Herbert, P. Lim, P. Deshpande, C. Becavin, V. Guiyedi et al. 2009. IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India. PLoS One. 4:e8245.
19. Bard, F., C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda et al. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine. 6:916-919.
20. Bartos, A., L. Fialova, J. Svarcova, and D. Ripova. 2012. Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament. Journal of Neuroimmunology. 252:100-105.
21. Behan, P.O., L.M. Lowenstein, M. Stilmant, and D.S. Sax. 1973. Landry-Guillain-Barre-Strohl syndrome and immune-complex nephritis. Lancet. 1:850-854.
22. Ben-Ami, S.D., M. Blank, and A. Altman. 2010. [The clinical importance of anti-ribosomal-P antibodies]. Harefuah. 149:794-810.
23. Berg, D.K., and W.G. Conroy. 2002. Nicotinic alpha 7 receptors: Synaptic options and downstream signaling in neurons. Journal of Neurobiology. 53:512-523.
24. Berghs, S., F. Ferracci, E. Maksimova, S. Gleason, N. Leszczynski, M. Butler et al. 2001. Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome. Proceedings of the National Academy of Sciences of the United States of America. 98:6945-6950.
25. Berghs, S.A., D. Aggujaro, R. Dirkx, E. Maksimova, P. Stabach, J.M. Hermel et al. 2000. beta IV spectrin, a new spectrin localized at axon initial segments and nodes of Ranvier. The Journal of Cell Biology. 151:985-1002.
26. Beuche, W., and R.L. Friede. 1986. Myelin phagocytosis in Wallerian degeneration of peripheral nerves depends on silica-sensitive, bg/bg-negative and Fc-positive monocytes. Brain Research. 378:97-106.
27. Bitsch, A., A. Dressel, K. Meier, T. Bogumil, F. Deisenhammer, H. Tumanial et. 2004. Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b. Journal of Neurology. 251:1498-1501.
28. Bjorklund, H., M. Eriksdotter-Nilsson, D. Dahl, G. Rose, B. Hoffer, and L. Olson. 1985. Image analysis of GFA-positive astrocytes from adolescence to senescence. Experimental Brain Research. 58:163-170.
29. Blight, A.R. 1993. Remyelination, revascularization, and recovery of function in experimental spinal cord injury. Advances in Neurology. 59:91-104.
30. Blight, A.R. 1994. Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience. 60:263-273.
31. Borovikova, L.V., S. Ivanova, M. Zhang, H. Yang, G.I. Botchkina, L.R. Watkins et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405:458-462.
32. Braunschweig, D., P. Krakowiak, P. Duncanson, R. Boyce, R.L. Hansen, P. Ashwood et al. 2013. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Translational Psychiatry. 3:e277.
33. Braunschweig, D., P. Duncanson, R. Boyce, R. Hansen, P. Ashwood, I.N. Pessah, I. Hertz-Picciotto, and J. Van de Water. 2012. Behavioral correlates of maternal antibody status among children with autism. Journal of Autism and Developmental Disorders. 42:1435-1445.
34. Braunschweig, D., and J. Van de Water. 2012. Maternal autoantibodies in autism. Archives of Neurology. 69:693-699.
35. Braunschweig, D., P. Ashwood, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, L.A. Croen, I.N. Pessah et al. 2008. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology. 29:226-231.
36. Bressler, J.P., and G.W. Goldstein. 1991. Mechanisms of lead neurotoxicity. Biochemical Pharmacology. 41:479-484.
37. Brock, T.O., and J.P. O’Callaghan. 1987. Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. Journal of Neuroscience. 7:931-942.
38. Connolly, A.M., M. Chez, E.M. Streif, R.M. Keeling, P.T. Golumbek, J.M. Kwon et al. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biological Psychiatry. 59:354-363.
39. Connolly, A.M., M.G. Chez, A. Pestronk, S.T. Arnold, S. Mehta, and R.K. Deuel. 1999. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. The Journal of Pediatrics. 134:607-613.
40. Corcione, A., S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio et al, 2004a. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 101:11064-11069.
41. Corcione, A., S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio et al, 2004b. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 101:11064-11069.
42. Croonenberghs, J., E. Bosmans, D. Deboutte, G. Kenis, and M. Maes. 2002. Activation of the inflammatory response system in autism. Neuropsychobiology. 45:1-6.
43. Cross, A.H., J.L. Trotter, and J.A. Lyons. 2001. B cells and antibodies in CNS demyelinating disease. Journal of Neuroimmunology. 112:1-14.
44. Cruse, J.M., R.E. Lewis, D.L. Roe, S. Dilioglou, M.C. Blaine, W.F. Wallace et al. 2000. Facilitation of immune function, healing of pressure ulcers, and nutritional status in spinal cord injury patients. Experimental and Molecular Pathology. 68:38-54.
45. Dalakas, M.C, 2008a. B cells as therapeutic targets in autoimmune neurological disorders. Nature Clinical Practice. Neurology. 4:557-567.
46. Dalakas, M.C, 2008b. Invited article: Inhibition of B cell functions - Implications for neurology. Neurology. 70:2252-2260.
47. Dalakas, M.C, 2008c. Invited article: Inhibition of B cell functions: Implications for neurology. Neurology. 70:2252-2260.
48. Dalmau, J., and M.R. Rosenfeld. 2008. Paraneoplastic syndromes of the CNS. Lancet Neurology. 7:327-340.
49. Dalton, P., R. Deacon, A. Blamire, M. Pike, I. McKinlay, J. Stein et al. 2003. Maternal neuronal antibodies associated with autism and a language disorder. Annals of Neurology. 53:533-537.
50. Darnell, R.B., H.M. Furneaux, and J.B. Posner. 1991. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors. Journal of Neuroscience. 11:1224-1230.
51. Davidson, A., and B. Diamond. 2001. Advances in immunology - Autoimmune diseases. New England Journal of Medicine. 345:340-350.
52. Davies, A.L., K.C. Hayes, and G.A. Dekaban. 2007. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Archives of Physical Medicine and Rehabilitation. 88:1384-1393.
53. DeGiorgio, L.A., K.N. Konstantinov, S.C. Lee, J.A. Hardin, B.T. Volpe, and B. Diamond. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nature Medicine. 7:1189-1193.
54. Dekaban, G.A., and S. Thawer. 2009. Pathogenic antibodies are active participants in spinal cord injury. The Journal of Clinical Investigation. 119:2881-2884.
55. Diamond, B., G. Honig, S. Mader, L. Brimberg, and B.T. Volpe. 2013. Brain-reactive antibodies and disease. Annual Review of Immunology. 31:345-385.
56. Dicou, E., D. Hurez, and V. Nerriere. 1993. Natural autoantibodies against the nerve growth factor in autoimmune diseases. Journal of Neuroimmunology. 47:159-167.
57. Dorner, T., A. Radbruch, and G.R. Burmester. 2009. B-cell-directed therapies for autoimmune disease. Nature Reviews. Rheumatology. 5:433-441.
58. Drisdel, R.C., and W.N. Green. 2000. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. Journal of Neuroscience. 20:133-139.
59. Dudley, D.J. 1992. The immune-system in health and disease. Bailliere’s Clinical Obstetrics and Gynecology. 6:393-416.
60. Ekizoglu, E., E. Tuzun, M. Woodhall, B. Lang, L. Jacobson, S. Icoz et al. 2014. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia. 55:414-422.
61. El-Fawal, H.A., and W.C. McCain. 2008. Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration. Neurotoxicology and teratology. 30:161-166.
62. El-Fawal, H.A., S.J. Waterman, A. De Feo, and M.Y. Shamy. 1999. Neuroimmunotoxicology: Humoral assessment of neurotoxicity and autoimmune mechanisms. Environmental Health Perspectives. 107 Suppl 5:767-775.
63. Eng, L.F., J.J. Vanderhaeghen, A. Bignami, and B. Gerstl. 1971. An acidic protein isolated from fibrous astrocytes. Brain Research. 28:351-354.
64. Evans, H.L. 1995. Markers of neurotoxicity - from behavior to autoantibodies against brain proteins. Clinical Chemistry. 41:1874-1881.
65. Fairweather, D., and N.R. Rose. 2004. Women and autoimmune diseases. Emerging Infectious Diseases. 10:2005-2011.
66. Fazio, V., S.K. Bhudia, N. Marchi, B. Aumayr, and D. Janigro. 2004. Peripheral detection of S100beta during cardiothoracic surgery: What are we really measuring? The Annals of Thoracic Surgery. 78:46-52; discussion 52-43.
67. Fernandez-Shaw, C., A. Marina, P. Cazorla, F. Valdivieso, and J. Vazquez. 1997. Anti-brain spectrin immunoreactivity in Alzheimer’s disease: Degradation of spectrin in an animal model of cholinergic degeneration. Journal of Neuroimmunology. 77:91-98.
68. Fialova, L., A. Bartos, J. Svarcova, D. Zimova, and J. Kotoucova, 2013a. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. Journal of Neuroimmunology. 259:81-87.
69. Fialova, L., A. Bartos, J. Svarcova, D. Zimova, J. Kotoucova, and I. Malbohan, 2013b. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis. Journal of Neuroimmunology. 262:113-120.
70. Fleming, J.C., M.D. Norenberg, D.A. Ramsay, G.A. Dekaban, A.E. Marcillo, A.D. Saenz et al. 2006. The cellular inflammatory response in human spinal cords after injury. Brain. 129:3249-3269.
71. Floyd, S., M.H. Butler, O. Cremona, C. David, Z. Freyberg, X. Zhang et al. 1998. Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer. Molecular Medicine. 4:29-39.
72. Folli, F., M. Solimena, R. Cofiell, M. Austoni, G. Tallini, G. Fassetta et al. 1993. Autoantibodies to a 128-Kd synaptic protein in 3 women with the Stiff-Man Syndrome and breast-cancer. New England Journal of Medicine. 328:546-551.
73. Frye, R.E., J.M. Sequeira, E.V. Quadros, S.J. James, and D.A. Rossignol. 2013. Cerebral folate receptor autoantibodies in autism spectrum disorder. Molecular Psychiatry. 18:369-381.
74. Galea, I., I. Bechmann, and V.H. Perry. 2007. What is immune privilege (not)? Trends in Immunology. 28:12-18.
75. Genain, C.P., B. Cannella, S.L. Hauser, and C.S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine. 5:170-175.
76. Gitlits, V.M., J.W. Sentry, L.S. Matthew, A.I. Smith, and B.H. Toh. 2001. Synapsin I identified as a novel brain-specific autoantigen. Journal of Investigative Medicine. 49:276-283.
77. Goines, P., L. Haapanen, R. Boyce, P. Duncanson, D. Braunschweig, L. Delwiche et al. 2011. Autoantibodies to cerebellum in children with autism associate with behavior. Brain, Behavior, and Immunity. 25:514-523.
78. Goines, P., and J. Van de Water. 2010. The immune system’s role in the biology of autism. Current Opinion in Neurology. 23:111-117.
79. Gold, R., M. Stangel, and M.C. Dalakas. 2007. Drug Insight: The use of intravenous immunoglobulin in neurology - therapeutic considerations and practical issues. Nature Clinical Practice. Neurology. 3:36-44.
80. Gresa-Arribas, N., M.J. Titulaer, A. Torrents, E. Aguilar, L. McCracken, F. Leypoldt et al. 2014. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: A retrospective study. Lancet Neurology. 13:167-177.
81. Griot-Wenk, M., C. Griot, H. Pfister, and M. Vandevelde. 1991. Antibody-dependent cellular cytotoxicity in antimyelin antibody-induced oligodendrocyte damage in vitro. Journal of Neuroimmunology. 33:145-155.
82. Hayakawa, T., Y. Ushio, T. Mori, N. Arita, T. Yoshimine, Y. Maeda et al. 1979. Levels in stroke patients of CSF astroprotein, an astrocyte-specific cerebroprotein. Stroke. 10:685-689.
83. Hayes, K.C., T.C. Hull, G.A. Delaney, P.J. Potter, K.A. Sequeira, K. Campbell et al. 2002. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. Journal of Neurotrauma. 19:753-761.
84. Hedegaard, C.J., N. Chen, F. Sellebjerg, P.S. Sorensen, R.G. Leslie, K. Bendtzen et al. 2009. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: A role in regulating cytokine responses to MBP. Immunology. 128:e451-461.
85. Howe, C.L., A.J. Bieber, A.E. Warrington, L.R. Pease, and M. Rodriguez. 2004. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiology of Disease. 15:120-131.
86. Ingram, C.R., K.J. Phegan, and H.T. Blumenthal. 1974. Significance of an aging-linked neuron binding gamma globulin fraction of human sera. Journal of Gerontology. 29:20-27.
87. Iversen, P.O., N. Hjeltnes, B. Holm, T. Flatebo, I. Strom-Gundersen, W. Ronning et al. 2000. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood. 96:2081-2083.
88. Joachim, S.C., M.B. Wax, N. Boehm, D.R. Dirk, N. Pfeiffer, and F.H. Grus. 2011. Upregulation of antibody response to heat shock proteins and tissue antigens in an ocular ischemia model. Investigative Ophthalmology andand Visual Science. 52:3468-3474.
89. Jones, A.L., B.J. Mowry, D.E. McLean, B.X. Mantzioris, M.P. Pender, and J.M. Greer. 2014. Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia. Journal of Neuroimmunology. 269:68-75.
90. Kamchatnov, P.R., N.Y. Ruleva, S.F. Dugin, L.I. Buriachkovskaya, A.V. Chugunov, N.A. Mikhailova et al. 2009. Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke. Zhurnal Neurologii i Psikhiatrii. 109:69-72.
91. Kanada, M., M. Miyagawa, M. Sato, H. Hasegawa, and T. Honma. 1994. Neurochemical profile of effects of 28 neurotoxic chemicals on the central nervous system in rats (1). Effects of oral administration on brain contents of biogenic amines and metabolites. Industrial Health. 32:145-164.
92. Katz, D.H. 1980. Adaptive differentiation of lymphocytes: Theoretical implications for mechanisms of cell- cell recognition and regulation of immune responses. Advances in Immunology. 29:137-207.
93. Keller, J.N., and M.P. Mattson. 1998. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Reviews in the Neurosciences. 9:105-116.
94. Kelly, D.F., I.T. Gonzalo, P. Cohan, N. Berman, R. Swerdloff, and C. Wang. 2000. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A preliminary report. Journal of Neurosurgery. 93:743-752.
95. Kergonou, J.F., I. Pennacino, C. Lafite, and R. Ducousso. 1988. Immunological relevance of malonic dialdehyde (Mda). 2. Precipitation reactions of human-sera with Mda-crosslinked proteins. Biochemistry International. 16:835-843.
96. Kida, S., A. Pantazis, and R.O. Weller. 1993. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathology and Applied Neurobiology. 19:480-488.
97. Kigerl, K.A., V.M. McGaughy, and P.G. Popovich. 2006. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. The Journal of Comparative Neurology. 494:578-594.
98. Kil, K., Y.C. Zang, D. Yang, J. Markowski, G.S. Fuoco, G.C. Vendetti et al. 1999. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. Journal of Neuroimmunology. 98:201-207.
99. Kingsley, B.S., F. Gaskin, and S.M. Fu. 1988. Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer’s disease. Journal of Neuroimmunology. 19:89-99.
100. Kirkman, N.J., J.E. Libbey, T.L. Sweeten, H.H. Coon, J.N. Miller, E.K. Stevenson et al. 2008. How relevant are GFAP autoantibodies in autism and Tourette Syndrome? Journal of Autism and Developmental Disorders. 38:333-341.
101. Kliesch, W.F., J.M. Cruse, R.E. Lewis, G.R. Bishop, B. Brackin, and J.A. Lampton. 1996. Restoration of depressed immune function in spinal cord injury patients receiving rehabilitation therapy. Paraplegia. 34:82-90.
102. Kowal, C., L.A. DeGiorgio, T. Nakaoka, H. Hetherington, P.T. Huerta, B. Diamond et al. 2004. Cognition and immunity; antibody impairs memory. Immunity. 21:179-188.
103. Le Couteur, A., G. Haden, D. Hammal, and H. McConachie. 2008. Diagnosing autism spectrum disorders in pre-school children using two standardised assessment instruments: The ADI-R and the ADOS. Journal of Autism and Developmental Disorders. 38:362-372.
104. Levesque, M.C., and E.W. St Clair. 2008. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. The Journal of Allergy and Clinical Immunology. 121:13-21; quiz 22-33.
105. Levy, N.L., M.S. Mahaley, Jr., and E.D. Day. 1972. In vitro demonstration of cell-mediated immunity to human brain tumors. Cancer Research. 32:477-482.
106. Lord, C., E.H. Cook, B.L. Leventhal, and D.G. Amaral, 2000a. Autism spectrum disorders. Neuron. 28:355-363.
107. Lord, C., A. Pickles, J. McLennan, M. Rutter, J. Bregman, S. Folstein et al. 1997. Diagnosing autism: Analyses of data from the Autism Diagnostic Interview. Journal of Autism and Developmental Disorders. 27:501-517.
108. Lord, C., S. Risi, L. Lambrecht, E.H. Cook, Jr., B.L. Leventhal, P.C. DiLavore et al, 2000b. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders. 30:205-223.
109. Lord, C., M. Rutter, and A. Le Couteur. 1994. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders. 24:659-685.
110. Lotti, M. 1995. Cholinesterase inhibition: Complexities in interpretation. Clinical Chemistry. 41:1814-1818.
111. Lu, X.Y., X.X. Chen, L.D. Huang, C.Q. Zhu, Y.Y. Gu, and S. Ye. 2010. Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis. PLoS One. 5:e11124.
112. Lucin, K.M., V.M. Sanders, T.B. Jones, W.B. Malarkey, and P.G. Popovich. 2007. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Experimental Neurology. 207:75-84.
113. Lyons, J.A., M. San, M.P. Happ, and A.H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. European Journal of Immunology. 29:3432-3439.
114. Maetzler, W., D. Berg, M. Synofzik, K. Brockmann, J. Godau, A. Melms et al. 2011. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. Journal of Alzheimer’s disease. 26:171-179.
115. Mailman, R.B., and M.H. Lewis. 1987. Neurotoxicants and central catecholamine systems. Neurotoxicology. 8:123-139.
116. Malek, A., R. Sager, P. Kuhn, K.H. Nicolaides, and H. Schneider. 1996. Evolution of maternofetal transport of immunoglobulins during human pregnancy. American Journal of Reproductive Immunology. 36:248-255.
117. Marchi, N., J.J. Bazarian, V. Puvenna, M. Janigro, C. Ghosh, J. Zhong et al, 2013a. Consequences of repeated blood-brain barrier disruption in football players. PloS One. 8:e56805.
118. Marchi, N., J.J. Bazarian, V. Puvenna, M. Janigro, C. Ghosh, J.H. Zhong et al, 2013b. Consequences of repeated blood-brain barrier disruption in football players. PloS One. 8:e56805.
119. Marchi, N., M. Cavaglia, V. Fazio, S. Bhudia, K. Hallene, and D. Janigro. 2004. Peripheral markers of blood-brain barrier damage. Clinica Chimica Acta. 342:1-12.
120. Marchi, N., P. Rasmussen, M. Kapural, V. Fazio, K. Kight, M.R. Mayberg et al. 2003. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restorative Neurology and Neuroscience. 21:109-121.
121. Martin, L.A., P. Ashwood, D. Braunschweig, M. Cabanlit, J. Van de Water, and D.G. Amaral. 2008. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain, Behavior, and Immunity. 22:806-816.
122. Mason, D.L., M.M. Assimon, J.R. Bishop, and H.A. El-Fawal. 2013. Nervous system autoantibodies and vitamin D receptor gene polymorphisms in hemodialysis patients. Hemodialysis International. 17:3-11.
123. Matsushita, T., and T.F. Tedder. 2009. B-lymphocyte depletion for the treatment of multiple sclerosis: Now things really get interesting. Expert Review of Neurotherapeutics. 9:309-312.
124. Mcraedegueurce, A., S. Booj, K. Haglid, L. Rosengren, J.E. Karlsson, I. Karlsson et al. 1987. Antibodies in cerebrospinal-fluid of some Alzheimer-disease patients recognize cholinergic neurons in the rat central nervous-system. Proceedings of the National Academy of Sciences of the United States of America. 84:9214-9218.
125. Mecocci, P., L. Parnetti, R. Donato, C. Santucci, A. Santucci, D. Cadini et al. 1992. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain, Behavior, and Immunity. 6:286-292.
126. Mizrachi, Y., A. Ohry, A. Aviel, R. Rozin, M.E. Brooks, and M. Schwartz. 1983. Systemic humoral factors participating in the course of spinal cord injury. Paraplegia. 21:287-293.
127. Moneim, I.A., M.Y. Shamy, R.M. el-Gazzar, and H.A. El-Fawal. 1999. Autoantibodies to neurofilaments (NF), glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) in workers exposed to lead. The Journal of the Egyptian Public Health Association. 74:121-138.
128. Moody, M., M. Zipp, and I. Al-Hashimi. 2001. Salivary anti-spectrin autoantibodies in Sjogren’s syndrome. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 91:322-327.
129. Moretto, A., M. Bertolazzi, and M. Lotti. 1994. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicology and Applied Pharmacology. 129:133-137.
130. Mori, T., K. Morimoto, T. Hayakawa, Y. Ushio, H. Mogami, and K. Sekiguchi. 1978. Radioimmunoassay of astroprotein (an astrocyte-specific cerebroprotein) in cerebrospinal fluid and its clinical significance. Neurologia Medico-chirurgica. 18:25-31.
131. Morris, C.M., C. Pardo-Villamizar, C.D. Gause, and H.S. Singer. 2009. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. Journal of the Neurological Sciences. 276:45-48.
132. Mosley, K., and M.L. Cuzner. 1996. Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents. Neurochemical Research. 21:481-487.
133. Mostafa, G.A., and L.Y. Al-Ayadhi. 2011. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. Journal of Neuroinflammation. 8:180.
134. Mostafa, G.A., D.H. Ibrahim, A.A. Shehab, and A.K. Mohammed. 2010. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. Journal of Neuroimmunology. 227:195-201.
135. Mundiyanapurath, S., S. Jarius, C. Probst, W. Stocker, B. Wildemann, and J. Bosel. 2013. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. Journal of Neuroimmunology. 259:88-91.
136. Murakami, H., S. Iijima, M. Kawamura, Y. Takahashi, and H. Ichikawa. 2013. [A case of acute cerebellar ataxia following infectious mononucleosis accompanied by intrathecal anti-glutamate receptor delta2 antibody]. Rinsho shinkeigaku. 53:555-558.
137. Murphy, W.H., M.R. Tam, R.L. Lanzi, M.R. Abell, and C. Kauffman. 1970. Age dependence of immunologically induced central nervous system disease in C58 mice. Cancer Research. 30:1612-1622.
138. Nandy, K. 1972. Brain-reactive antibodies in mouse serum as a function of age. Journal of Gerontology. 27:173-177.
139. Neuwelt, E.A., B. Bauer, C. Fahlke, G. Fricker, C. Iadecola, D. Janigro et al. 2011. Engaging neuroscience to advance translational research in brain barrier biology. Nature Reviews. Neuroscience. 12:169-182.
140. Ngankam, L., N.V. Kazantseva, and M.M. Gerasimova. 2011. Immunological markers of severity and outcome of traumatic brain injury. Zhurnal Neurologii i Psikhiatrii. 111:61-65.
141. Niebroj-Dobosz, I., D. Dziewulska, and P. Janik. 2006. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathologica. 44:191-196.
142. National Institutes of Health Autoimmune Diseases Coordinating Committee Report. 2002. Autoimmune Diseases Research Plan. National Institutes of Health, Bethesda, MD.
143. Op De Beeck, K., K. Van den Bergh, S. Vermeire, S. Decock, R. Derua, E. Waelkens et al. 2011. Immune reactivity to beta-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders. Gut. 60:1601-1602.
144. Outteryck, O., G. Baille, J. Hodel, M. Giroux, A. Lacour, J. Honnorat et al. 2013. Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurology. 13:211.
145. Pardo, C.A., D.L. Vargas, and A.W. Zimmerman. 2005. Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry. 17:485-495.
146. Pavlowsky, A., A. Gianfelice, M. Pallotto, A. Zanchi, H. Vara, M. Khelfaoui et al. 2010. A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Current Biology. 20:103-115.
147. Paz Soldan, M.M., A.E. Warrington, A.J. Bieber, B. Ciric, V. Van Keulen, L.R. Pease et al. 2003. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: Relationship to the mechanism of myelin repair. Molecular and Cellular Neurosciences. 22:14-24.
148. Pinelis, V.G., and E.G. Sorokina. 2008. [Autoimmune mechanisms of modulation of the activity of glutamate receptors in children with epilepsy and craniocerebral injury]. Vestnik Rossiiskoi akademii meditsinskikh nauk/Rossiiskaia akademiia meditsinskikh nauk. 44-51.
149. Pirko, I., B. Ciric, J. Gamez, A.J. Bieber, A.E. Warrington, A.J. Johnson et al. 2004. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB Journal. 18:1577-1579.
150. Piton, A., J.L. Michaud, H. Peng, S. Aradhya, J. Gauthier, L. Mottron et al. 2008. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Human Molecular Genetics. 17:3965-3974.
151. Poletaev, A., and P. Boura. 2011. The immune system, natural autoantibodies and general homeostasis in health and disease. Hippokratia. 15:295-298.
152. Popovic, M., M. Caballero-Bleda, L. Puelles, N. Popovic, and N. Popovic. 1998. Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer’s disease. International Journal of Neuroscience. 95:203-236.
153. Popovich, P.G., Z. Guan, P. Wei, I. Huitinga, N. van Rooijen, and B.T. Stokes. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Experimental Neurology. 158:351-365.
154. Porcelli, B., F. Ferretti, C. Vindigni, C. Scapellato, and L. Terzuoli. 2013. Detection of autoantibodies against actin filaments in celiac disease. Journal of Clinical Laboratory Analysis. 27:21-26.
155. Posner, J.B., and J. Dalmau, 1997a. Paraneoplastic syndromes. Current Opinion in Immunology. 9:723-729.
156. Posner, J.B., and J.O. Dalmau, 1997b. Paraneoplastic syndromes affecting the central nervous system. Annual Review of Medicine. 48:157-166.
157. Prinz, M., J. Priller, S.S. Sisodia, and R.M. Ransohoff. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature Neuroscience. 14:1227-1235.
158. Raine, C.S., B. Cannella, S.L. Hauser, and C.P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation. Annals of Neurology. 46:144-160.
159. Ramaekers, V.T., E.V. Quadros, and J.M. Sequeira. 2013. Role of folate receptor autoantibodies in infantile autism. Molecular Psychiatry. 18:270-271.
160. Reiber, H. 2001. Dynamics of brain-derived proteins in cerebrospinal fluid. Clinica Chimica Acta. 310:173-186.
161. Reiber, H. 2003. Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restorative Neurology and Neuroscience. 21:79-96.
162. Rosas-Ballina, M., and K.J. Tracey. 2009. Cholinergic control of inflammation. Journal of Internal Medicine. 265:663-679.
163. Rothenberg, S.P., M.P. da Costa, J.M. Sequeira, J. Cracco, J.L. Roberts, J. Weedon et al. 2004. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. The New England Journal of Medicine. 350:134-142.
164. Rudehill, S., S. Muhallab, A. Wennersten, C. von Gertten, F. Al Nimer, A.C. Sandberg-Nordqvist et al. 2006. Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats. Acta Neurochirurgia. 148:199-205.
165. Schwartz, M., and J. Kipnis. 2001. Protective autoimmunity: Regulation and prospects for vaccination after brain and spinal cord injuries. Trends in Molecular Medicine. 7:252-258.
166. Simister, N.E. 2003. Placental transport of immunoglobulin G. Vaccine. 21:3365-3369.
167. Singer, H.S., C. Morris, C. Gause, M. Pollard, A.W. Zimmerman, and M. Pletnikov. 2009. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model. Journal of Neuroimmunology. 211:39-48.
168. Singer, H.S., C.M. Morris, P.N. Williams, D.Y. Yoon, J.J. Hong, and A.W. Zimmerman. 2006. Antibrain antibodies in children with autism and their unaffected siblings. Journal of Neuroimmunology. 178:149-155.
169. Singh, V.K., R.P. Warren, J.D. Odell, W.L. Warren, and P. Cole. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain, Behavior, and Immunity. 7:97-103.
170. Sjogren, M., and A. Wallin. 2001. Pathophysiological aspects of frontotemporal dementia - emphasis on cytoskeleton proteins and autoimmunity. Mechanisms of Ageing and Development. 122:1923-1935.
171. Skoda, D., K. Kranda, M. Bojar, L. Glosova, J. Baurle, J. Kenney et al. 2006. Antibody formation against beta-tubulin class III in response to brain trauma. Brain Research Bulletin. 68:213-216.
172. Skouen, J.S., J.L. Larsen, and S.E. Vollset. 1993. Cerebrospinal fluid proteins as indicators of nerve root compression in patients with sciatica caused by disc herniation. Spine. 18:72-79.
173. Soares, H.D., R.R. Hicks, D. Smith, and T.K. McIntosh. 1995. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. Journal of Neuroscience. 15:8223-8233.
174. Sorokina, E.G., J.B. Semenova, O.K. Granstrem, O.V. Karaseva, S.V. Meshcheryakov, V.P. Reutov et al. 2010. S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children. Zhurnal Neurologii i Psikhiatrii. 110:30-35.
175. Sorokina, E.G., Zh.B. Semenova, N.A. Bazarnaya, S.V. Meshcheryakov, V.P. Reutov, A.V. Goryunova et al. 2009. Autoantibodies to glutamate receptors and products of nitric oxide metabolism in serum in children in the acute phase of craniocerebral trauma. Neuroscience and Behavioral Physiology. 39:329-334.
176. Sorokina, E.G., T.P. Storozhevykh, Y.E. Senilova, O.K. Granstrem, V.P. Reutov, and V.G. Pinelis. 2006. Effect of antibodies against AMPA glutamate receptors on brain neurons in primary cultures of the cerebellum and hippocampus. Bulletin of Experimental Biology and Medicine. 142:51-54.
177. Sorokina, E.G., O.M. Vol’pina, B. Semenova Zh, O.V. Karaseva, D.O. Koroev, A.V. Kamynina et al. 2011. [Autoantibodies to alpha7-subunit of neuronal acetylcholine receptor in children with traumatic brain injury]. Zhurnal Nevrologii i Psikhiatrii. 111:56-60.
178. Sotgiu, S., A. Giua, M.R. Murrighile, and R. Ortu. 2009. A case of anti-myelin-associated glycoprotein polyneuropathy and multiple sclerosis: One disease instead of two? BMJ Case Reports. 2009.
179. Sroga, J.M., T.B. Jones, K.A. Kigerl, V.M. McGaughy, and P.G. Popovich. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. The Journal of Comparative Neurology. 462:223-240.
180. Stefanova, I., J.R. Dorfman, and R.N. Germain. 2002. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature. 420:429-434.
181. Stein, T.D., J.P. Fedynyshyn, and R.E. Kalil. 2002. Circulating autoantibodies recognize and bind dying neurons following injury to the brain. Journal of Neuropathology and Experimental Neurology. 61:1100-1108.
182. Stellwagen, D., and R.C. Malenka. 2006. Synaptic scaling mediated by glial TNF-alpha. Nature. 440:1054-1059.
183. Stephan, A.H., B.A. Barres, and B. Stevens. 2012. The complement system: An unexpected role in synaptic pruning during development and disease. Annual Review of Neuroscience. 35:369-389.
184. Storoni, M., A. Petzold, and G.T. Plant. 2011. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis. PloS One. 6:e23489.
185. Sundstrom, R., and H. Kalimo. 1987. Extracellular edema and glial response to it in the cerebellum of suckling rats with low-dose lead encephalopathy. An electron microscopic and immunohistochemical study. Acta Neuropathologica. 75:116-122.
186. Sundstrom, R., K. Muntzing, H. Kalimo, and P. Sourander. 1985. Changes in the integrity of the blood-brain barrier in suckling rats with low dose lead encephalopathy. Acta Neuropathologica. 68:1-9.
187. Tanaka, J., K. Murakoshi, M. Takeda, Y. Kato, K. Tada, S. Hariguchi et al. 1988. A high-level of anti-GFAP autoantibody in the serum of patients with Alzheimer’s disease. Biomedical Research-Tokyo. 9:209-216.
188. Tanaka, J., K. Nakamura, M. Takeda, K. Tada, H. Suzuki, H. Morita et al. 1989. Enzyme-linked immunosorbent-assay for human autoantibody to glial fibrillary acidic protein - higher titer of the antibody is detected in serum of patients with Alzheimer’s disease. Acta Neurologica Scandinavia. 80:554-560.
189. Tanriverdi, F., A. De Bellis, M. Battaglia, G. Bellastella, A. Bizzarro, A.A. Sinisi et al. 2010. Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: Is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? European Journal of Endocrinology. 162:861-867.
190. Tanriverdi, F., A. De Bellis, A. Bizzarro, A.A. Sinisi, G. Bellastella, E. Pane et al, 2008a. Antipituitary antibodies after traumatic brain injury: Is head trauma-induced pituitary dysfunction associated with autoimmunity? European Journal of Endocrinology/European Federation of Endocrine Societies. 159:7-13.
191. Tanriverdi, F., H. Senyurek, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, and F. Kelestimur. 2006. High risk of hypopituitarism after traumatic brain injury: A prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. The Journal of Clinical Endocrinology and Metabolism. 91:2105-2111.
192. Tanriverdi, F., H. Ulutabanca, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, and F. Kelestimur, 2008b. Three years prospective investigation of anterior pituitary function after traumatic brain injury: A pilot study. Clinical Endocrinology. 68:573-579.
193. Terry, R.D., and H. Wisnewski. 1972. Ultrastructure of senile dementia and of experimental analogs. In Aging and the Brain. Plenum Press, New York,.
194. Thomas, L., A. Mailles, V. Desestret, F. Ducray, E. Mathias, V. Rogemond et al. 2014. Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis. The Journal of Infection. 68:419-425.
195. Threatt, J., K. Nandy, and R. Fritz. 1971. Brain-reactive antibodies in serum of old mice demonstrated by immunofluorescence. Journal of Gerontology. 26:316-323.
196. Todd, R.D., J.M. Hickok, G.M. Anderson, and D.J. Cohen. 1988. Antibrain antibodies in infantile autism. Biological Psychiatry. 23:644-647.
197. Trippe, J., K. Steinke, A. Orth, P.M. Faustmann, M. Hollmann, and C.G. Haase. 2014. Autoantibodies to glutamate receptor antigens in multiple sclerosis and Rasmussen’s encephalitis. Neuroimmunomodulation. 21:189-194.
198. Tron, F. 2014. [Autoantibodies as biomarkers]. Presse Medicále. 43:57-65.
199. Tsuburaya, R.S., N. Miki, K. Tanaka, T. Kageyama, K. Irahara, S. Mukaida et al. 2014. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Brain and Development. Feb 28.
200. Tsuchiya, H., S. Haga, Y. Takahashi, T. Kano, Y. Ishizaka, and A. Mimori. 2014. Identification of novel autoantibodies to GABAB receptors in patients with neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford). 53:1219-1228.
201. Uchida, K., and E.R. Stadtman. 1992. Modification of histidine-residues in proteins by reaction with 4-hydroxynonenal. Proceedings of the National Academy of Sciences of the United States of America. 89:4544-4548.
202. Ulvestad, E., K. Williams, R. Matre, H. Nyland, A. Olivier, and J. Antel. 1994. Fc-receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol. 53:27-36.
203. van Gent, T., C.J. Heijnen, and P.D. Treffers. 1997. Autism and the immune system. Journal of child Psychology and Psychiatry, and Allied Disciplines. 38:337-349.
204. Vargas, D.L., C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology. 57:67-81.
205. Veerhuis, R., H.M. Nielsen, and A.J. Tenner. 2011. Complement in the brain. Molecular Immunology. 48:1592-1603.
206. Vincent, A., C.G. Bien, S.R. Irani, and P. Waters. 2011. Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurology. 10:759-772.
207. Vlajkovic, S., and B.D. Jankovic. 1991. Experimental epilepsy in vitro: Neuromodulating activity of anti-brain autoantibodies from rats exposed to electroconvulsive shock. International Journal of Neuroscience. 59:205-211.
208. Vojdani, A., M. Bazargan, E. Vojdani, J. Samadi, A.A. Nourian, N. Eghbalieh et al. 2004. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clinical and Diagnostic Laboratory Immunology. 11:515-524.
209. Wang, H., K.L. Munger, M. Reindl, E.J. O’Reilly, L.I. Levin, T. Berger et al. 2008. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology. 71:1142-1146.
210. Wang, K.K.W. 2000. Calpain and caspase: Can you tell the difference? Trends in Neurosciences. 23:59-59.
211. Wang, Y.Z., F.F. Tian, M. Yan, J.M. Zhang, Q. Liu, J.Y. Lu et al. 2014. Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis. Clinical and Experimental Immunology. 176:207-221.
212. Warren, R.P., A. Foster, and N.C. Margaretten. 1987. Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry. 26:333-335.
213. Warren, R.P., V.K. Singh, R.E. Averett, J.D. Odell, A. Maciulis, R.A. Burger et al. 1996. Immunogenetic studies in autism and related disorders. Molecular and Chemical Neuropathology. 28:77-81.
214. Waubant, E. 2008. Spotlight on anti-CD20. International MS Journal/MS Forum. 15:19-25.
215. Whitney, K.D., and J.O. McNamara. 2000. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. Journal of Neuroscience. 20:7307-7316.
216. Willenborg, D.O., and S.J. Prowse. 1983. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. Journal of Neuroimmunology. 5:99-109.
217. Wills, S., M. Cabanlit, J. Bennett, P. Ashwood, D.G. Amaral, and J. Van de Water. 2009. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain, Behavior, and Immunity. 23:64-74.
218. Wills, S., C.C. Rossi, J. Bennett, V.M. Cerdenño, P. Ashwood, D.G. Amaral et al, 2011a. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Molecular Autism. 2:5.
219. Wills, S., C.C. Rossi, J. Bennett, V. Martinez Cerdeno, P. Ashwood, D.G. Amaral et al, 2011b. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Molecular Autism. 2:5.
220. Winder, C., and J.C. Balouet. 2002. The toxicity of commercial jet oils. Environmental Research. 89:146-164.
221. Wright, B.R., A.E. Warrington, D.E. Edberg, and M. Rodriguez. 2009. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Archives of Neurology. 66:1456-1459.
222. Xing, G.Q., M. Ren, W.A. Watson, J.T. O’Neil, and A. Verma, 2009a. Traumatic brain injury-induced expression and phosphorylation of pyruvate dehydrogenase: A mechanism of dysregulated glucose metabolism. Neuroscience Letters. 454:38-42.
223. Xing, G.Q., M. Ren, W.D. Watson, J.T. O’Neill, and A. Verma, 2009b. Traumatic brain injury-induced expression and phosphorylation of pyruvate dehydrogenase: A mechanism of dysregulated glucose metabolism. Neuroscience Letters. 463:258-258.
224. Yahya, M.D., J.L. Pinnas, G.C. Meinke, and C.C. Lung. 1996. Antibodies against malondialdehyde (MDA) in MRL/lpr/pr mice: Evidence for an autoimmune mechanism involving lipid peroxidation. Journal of Autoimmunity. 9:3-9.
225. Yang, L., P.C. Blumbergs, N.R. Jones, J. Manavis, G.T. Sarvestani, and M.N. Ghabriel. 2004. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine. 29:966-971.
226. Younger, D.S., L.P. Rowland, N. Latov, A.P. Hays, D.J. Lange, W. Sherman et al. 1991. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Annals of Neurology. 29:78-86.
227. Yuan, X.Q., and C.E. Wade. 1991. Neuroendocrine abnormalities in patients with traumatic brain injury. Frontiers in Neuroendocrinology. 12:209-230.
228. Zachou, K., K. Oikonomou, Y. Renaudineau, A. Chauveau, N. Gatselis, P. Youinou et al. 2012. Anti-alpha actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1. Alimentary Pharmacology and Therapeutics. 35:116-125.
229. Zahran, W.E., M.I. Mahmoud, K.A. Shalaby, and M.H. Abbas. 2013. Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients. Indian Journal of Clinical Biochemistry. 28:272-276.
230. Zhang, M., E.M. Alicot, and M.C. Carroll. 2008. Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Molecular Immunology. 45:4036-4039.
231. Zhang, M., K. Takahashi, E.M. Alicot, T. Vorup-Jensen, B. Kessler, S. Thiel et al. 2006. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. Journal of Immunology. 177:4727-4734.
232. Zhang, Z., J.S. Zoltewicz, S. Mondello, K.J. Newsom, Z. Yang, B. Yang et al. 2014. Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PloS One. 9:e92698.
233. Zheng, W.R., M.C. Liu, R.L. Hayes, and K.K.W. Wang. 2008. Calpain and caspase mediated proteolysis of alpha II-spectrin and beta II-spectrin in rat cerebrocortical culture under oncotic, apoptotic and excitotoxic challenges. Journal of Neurotrauma. 25:900-900.
234. Zolotova, T.V., and I.E. Grebeniuk. 2010. [Serum level of anti-neurotrophine antibodies and activity of proteolytic enzymes in patients with sensorineural loss of hearing]. Vestnik Otorinolaringologii 25-28.